BIOMAT Database Logo BIOMAT Database Logo

Fetal and neonatal effects of indomethacin used as a tocolytic agent. 1985

D Veersema, and P A de Jong, and J A van Wijck

UI MeSH Term Description Entries
D007213 Indomethacin A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES. Amuno,Indocid,Indocin,Indomet 140,Indometacin,Indomethacin Hydrochloride,Metindol,Osmosin
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D007752 Obstetric Labor, Premature Onset of OBSTETRIC LABOR before term (TERM BIRTH) but usually after the FETUS has become viable. In humans, it occurs sometime during the 29th through 38th week of PREGNANCY. TOCOLYSIS inhibits premature labor and can prevent the BIRTH of premature infants (INFANT, PREMATURE). Preterm Labor,Labor, Premature,Premature Labor,Premature Obstetric Labor,Labor, Premature Obstetric,Labor, Preterm
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D005260 Female Females
D005333 Fetus The unborn young of a viviparous mammal, in the postembryonic period, after the major structures have been outlined. In humans, the unborn young from the end of the eighth week after CONCEPTION until BIRTH, as distinguished from the earlier EMBRYO, MAMMALIAN. Fetal Structures,Fetal Tissue,Fetuses,Mummified Fetus,Retained Fetus,Fetal Structure,Fetal Tissues,Fetus, Mummified,Fetus, Retained,Structure, Fetal,Structures, Fetal,Tissue, Fetal,Tissues, Fetal
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

D Veersema, and P A de Jong, and J A van Wijck
Fetal and neonatal effects of indomethacin used as a tocolytic agent.
January 1985, American journal of obstetrics and gynecology,
D Veersema, and P A de Jong, and J A van Wijck
Fetal and neonatal effects of indomethacin used as a tocolytic agent.
November 1985, American journal of obstetrics and gynecology,
D Veersema, and P A de Jong, and J A van Wijck
[Indomethacin and a tocolytic agent: fetal and neonatal outcome].
December 1990, Harefuah,
D Veersema, and P A de Jong, and J A van Wijck
Prenatal administration of indomethacin as a tocolytic agent: effect on neonatal renal function.
October 1990, Obstetrics and gynecology,
D Veersema, and P A de Jong, and J A van Wijck
Indomethacin as a tocolytic agent: the controversy continues.
May 1994, The Journal of pediatrics,
D Veersema, and P A de Jong, and J A van Wijck
Can a cyclo-oxygenase type-2 selective tocolytic agent avoid the fetal side effects of indomethacin?
March 2001, BJOG : an international journal of obstetrics and gynaecology,
D Veersema, and P A de Jong, and J A van Wijck
Tocolytic indomethacin: effects on neonatal haemodynamics and cerebral autoregulation in the preterm newborn.
September 2013, Archives of disease in childhood. Fetal and neonatal edition,
D Veersema, and P A de Jong, and J A van Wijck
The relationship between antenatal indomethacin as a tocolytic drug and neonatal outcomes: a retrospective cohort study.
September 2021, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians,
D Veersema, and P A de Jong, and J A van Wijck
Indomethacin as a tocolytic harmful to preterm infant.
December 2015, American journal of obstetrics and gynecology,
D Veersema, and P A de Jong, and J A van Wijck
Magnesium sulfate as a tocolytic agent.
August 2001, Seminars in perinatology,
Copied contents to your clipboard!